SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
1727913
Source:
http://linkedlifedata.com/resource/pubmed/id/1727913
Search
Subject
(
60
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0006142
,
umls-concept:C0013089
,
umls-concept:C0023636
,
umls-concept:C0043210
,
umls-concept:C0087111
,
umls-concept:C0733406
pubmed:issue
1
pubmed:dateCreated
1992-1-27
pubmed:abstractText
To test potential protection by ICRF-187 against cumulative doxorubicin-dose-related cardiac toxicity, we conducted a randomized clinical trial in 150 women with advanced breast cancer.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/36524
,
http://linkedlifedata.com/resource/pubmed/grant/CA-16087
,
http://linkedlifedata.com/resource/pubmed/grant/CRC-RR-99
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1727913
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin
,
http://linkedlifedata.com/resource/pubmed/chemical/Razoxane
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0732-183X
pubmed:author
pubmed-author:FerransVV
,
pubmed-author:GreenM DMD
,
pubmed-author:HochsterHH
,
pubmed-author:KramerEE
,
pubmed-author:MeyersMM
,
pubmed-author:ReyMM
,
pubmed-author:SangerJJ
,
pubmed-author:SpeyerJ LJL
,
pubmed-author:WernzJ CJC
,
pubmed-author:Zeleniuch-JacquotteAA
pubmed:issnType
Print
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
117-27
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:1727913-Adult
,
pubmed-meshheading:1727913-Aged
,
pubmed-meshheading:1727913-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:1727913-Breast Neoplasms
,
pubmed-meshheading:1727913-Doxorubicin
,
pubmed-meshheading:1727913-Female
,
pubmed-meshheading:1727913-Heart Failure
,
pubmed-meshheading:1727913-Humans
,
pubmed-meshheading:1727913-Life Tables
,
pubmed-meshheading:1727913-Middle Aged
,
pubmed-meshheading:1727913-Razoxane
,
pubmed-meshheading:1727913-Regression Analysis
,
pubmed-meshheading:1727913-Survival Analysis
,
pubmed-meshheading:1727913-Ventricular Function, Left
pubmed:year
1992
pubmed:articleTitle
ICRF-187 permits longer treatment with doxorubicin in women with breast cancer.
pubmed:affiliation
Department of Medicine, Rita and Stanley Kaplan Cancer Center, New York, NY.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, U.S. Gov't, P.H.S.
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't